An immunohistochemical study in a fatality due to ovarian hyperstimulation syndrome

International Journal of Legal Medicine

Volumn 120, Issue 5, 2006, Pages 293-299

  Fineschi, Vittorio ^a   Neri, Margherita ^a   Di Donato, Sabina ^a   Pomara, Cristoforo ^a   Riezzo, Irene ^a   Turillazzi, Emanuela ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Adult respiratory distress syndrome; Assisted reproduction techniques; Death; Immunohistochemistry; Ovarian hyperstimulation syndrome

Indexed keywords

CHORIONIC GONADOTROPIN ANTIBODY; INTERLEUKIN 6 ANTIBODY; INTERLEUKIN 8 ANTIBODY; MONOCLONAL ANTIBODY; RECOMBINANT FOLLITROPIN; SURFACTANT; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; AUTOPSY; CASE REPORT; CAUSE OF DEATH; DISEASE SEVERITY; FATALITY; FEMALE; FORENSIC PATHOLOGY; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCIDENCE; INFERTILITY THERAPY; LUTEAL PHASE; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PRIORITY JOURNAL;

ADULT; FATAL OUTCOME; FEMALE; FOLLICLE STIMULATING HORMONE, HUMAN; HUMANS; OVARIAN HYPERSTIMULATION SYNDROME; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 33747348139     PISSN: 09379827     EISSN: 14371596     Source Type: Journal    
DOI: 10.1007/s00414-006-0104-z     Document Type: Article

References (26)

1. Beerendonk CC, Van Dop PA, Braat DD, Merkus JM (1998) Ovarian hyperstimulation syndrome: facts and fallacies. Obstet Gynecol Surv 53:439-449
2. Fineschi V, Neri M, Turillazzi E (2005) The new Italian law on assisted reproduction technology (Law 40/2004). J Med Ethics 31:536-539
3. Delvigne A, Rozenberg S (2002) Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update 8:559-577
4. Abramov Y, Elchalal U, Schenker JG (1999) Severe OHSS: An 'epidemic' of severe OHSS: a price we have to pay? Hum Reprod 14:2181-2183
5. Papanikolaou EG, Tournaye H, Verpoest W, Camus M, Vernaeve V, Van Steirteghem A et al (2005) Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile. Hum Reprod 20:636-641
6. Mozes M, Bogokowski H, Antebi E et al (1965) Thromboembolic phenomena after ovarian stimulation with human gonadotrophins. Lancet 2:1213-1215
7. Cluroe AD, Synek BJ (1995) A fatal case of ovarian hyperstimulation syndrome with cerebral infarction. Pathology 27:344-346
8. Semba S, Moriya T, Youssef EM, Sasano H (2000) An autopsy case of ovarian hyperstimulation syndrome with massive pulmonary oedema and pleural effusion. Pathol Int 50:549-552
9. Roest J, Mous HV, Zeilmaker GH, Verhoeff A (1996) The incidence of major clinical complications in a Dutch transport IVF programme. Hum Reprod Update 2:345-353
10. Rabau E, David A, Serr DM et al (1967) Human menopausal gonadotropins for anovulation and sterility. Am J Obstet Gynecol 98:92-98
11. Schenker JG, Weinstein D (1978) Ovarian hyperstimulation syndrome: a current survey. Fertil Steril 30:255-268
12. Golan A, Ron-el R, Herman A, Soffer Y, Weinraub Z, Caspi E (1989) Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv 44:430-440
13. Navot D, Bergh PA, Laufer N (1992) Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril 58:249-261
14. Rizk B, Aboulghar MA (1999) Classification, pathophysiology and management of ovarian hyperstimulation syndrome. In: Brinsden P (ed) In vitro fertilization and assisted reproduction. Parthenon, New York London, pp 131-155
15. Aboulghar MA, Mansour RT (2003) Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures. Hum Reprod Update 9:275-289
16. Abramov Y, Elchalal U, Schenker JG (1999) Pulmonary manifestations of severe ovarian hyperstimulation syndrome: a multicenter study. Fertil Steril 71:645-651
17. Sugiyama K, Kawai T (1993) Diffuse alveolar damage and acute interstitial pneumonitis: histochemical evaluation with lectin and monoclonal antibodies against surfactant apoprotein and collagen type IV. Mod Pathol 6:242-248
18. Loret de Mola RJ, Arredondo-Soberon F, Randle CP, Tureck RT, Friedlander MA (1997) Markedly elevated cytokines in pleural effusion during the ovarian hyperstimulation syndrome: transudate or ascites? Fertil Steril 67:780-782
19. Practice Committee of the American Society for Reproductive Medicine (2003) Ovarian hyperstimulation syndrome. Fertil Steril 80:1309-1314
20. Venn A, Hemminki E, Watson L, Bruinsma F, Healy D (2001) Mortality in a cohort of IVF patients. Hum Reprod 16:2691-2696
21. Delvigne A, Rozenberg S (2003) Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS). Hum Reprod Update 9:77-96
22. Wedekind H, Schulze-Bahr E, Debus V, Breithardt G, Brinkmann B, Bajanowski T (2006) Cardiac arrhythmias and sudden death in infancy: implication for the medicolegal investigation. Int J Legal Med Jan 6:1-13. DOI 10.1007/s00414-005-0069-3
23. Laiho K (2004) Albumin as a marker of plasma transudation in experimental skin lesions. Int J Legal Med 118:282-288
24. Hayashi T, Ishida Y, Kimura A, Takayasu T, Eisenmenger W, Kondo T (2004) Forensic application of VEGF expression to skin wound age determination. Int J Legal Med 118:320-325
25. Reichelt U, Jung R, Nierhaus A, Tsokos M (2005) Serial monitoring of interleukin-1β, soluble interleukin-2 receptor and lipopolysaccharide binding protein levels after death. A comparative evaluation of potential postmortem markers of sepsis. Int J Legal Med 119:80-87
26. Bacci S, Romagnoli P, Norelli GA, Forestieri AL, Bonelli A (2006) Early increase in TNF-alpha-containing mast cells in skin lesions. Int J Legal Med 120:138-142